Cargando…
Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives
Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease of the central nervous system (CNS). Disease-modifying therapies (DMT) targeting inflammation have been shown to reduce disease activity in patients with relapsing–remitting MS (RRMS). The current therapeutic challen...
Autores principales: | Cuascut, Fernando X., Hutton, George J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631931/ https://www.ncbi.nlm.nih.gov/pubmed/30935074 http://dx.doi.org/10.3390/biomedicines7020026 |
Ejemplares similares
-
Current Advances in Pediatric Onset Multiple Sclerosis
por: Fisher, Kristen S., et al.
Publicado: (2020) -
Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States
por: Moore, Michael Z., et al.
Publicado: (2023) -
Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis
por: Mercado, Vicki, et al.
Publicado: (2020) -
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
por: Margoni, Monica, et al.
Publicado: (2021) -
Current concepts in multiple sclerosis therapy
por: Sedal, Leslie, et al.
Publicado: (2017)